Ryan Stansfield
Impact in
-
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
- RNA modifications and cancer
- DNA and Nucleic Acid Chemistry
- Protein Degradation and Inhibitors
- RNA and protein synthesis mechanisms
- DNA Repair Mechanisms
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Epigenetics and DNA Methylation 4
- Genomics and Chromatin Dynamics 2
- Glycosylation and Glycoproteins Research 1
- Protein Degradation and Inhibitors 1
- 14-3-3 protein interactions 1
- Co-authors
- James M. Veal (7 shared papers)Jeffrey A. Stafford (6 shared papers)Lihong Shi (5 shared papers)Chon Lai (4 shared papers)David J. Hosfield (4 shared papers)Shawn M. O’Connell (4 shared papers)Jiangchun Xu (4 shared papers)Zhe Nie (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (4 papers)ACS Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (1 paper)Cancer Research (1 paper)Blood (1 paper)
- Partner nations
- United StatesSwitzerlandPortugal
In The Last Decade
Ryan Stansfield
11 papers receiving 367 citations
Peers
Comparison fields: 5 of 52
- Molecular Biology 283
- Toxicology 7
- Organic Chemistry 61
- Oncology 51
- Cancer Research 21
Countries citing papers authored by Ryan Stansfield
This map shows the geographic impact of Ryan Stansfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Stansfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Stansfield more than expected).
Fields of papers citing papers by Ryan Stansfield
This network shows the impact of papers produced by Ryan Stansfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Stansfield. The network helps show where Ryan Stansfield may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Stansfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 121 | |
| 2 | 2020 | 96 | |
| 3 | 2017 | 55 | |
| 4 | 2018 | 33 | |
| 5 | 2011 | 30 | |
| 6 | 2018 | 12 | |
| 7 | 1990 | 10 | |
| 8 | 2018 | 9 | |
| 9 | 2024 | 5 | |
| 10 | 2012 | 3 | |
| 11 | 2018 | 1 |
About Ryan Stansfield
Ryan Stansfield is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Small Animals and Genetics, having authored 11 papers that have together received 375 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers), Genomics and Chromatin Dynamics (2 papers), Veterinary Medicine and Surgery (1 paper), Glycosylation and Glycoproteins Research (1 paper), Protein Degradation and Inhibitors (1 paper), 14-3-3 protein interactions (1 paper) and Quinazolinone synthesis and applications (1 paper). The work is most often cited by research in Molecular Biology (283 citations), Toxicology (7 citations), Organic Chemistry (61 citations), Oncology (51 citations) and Cancer Research (21 citations). Ryan Stansfield has collaborated with scholars based in United States, Switzerland and Portugal. Frequent co-authors include James M. Veal, Jeffrey A. Stafford, Lihong Shi, Chon Lai, David J. Hosfield, Shawn M. O’Connell, Jiangchun Xu, Zhe Nie, Mustapha Haddach and Levan Darjania. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.